Efficacy, Safety and Responder Subanalysis of Lenalidomide in Heavily Pretreated, Relapsed/Refractory Patients With Mantle Cell Lymphoma Post-Bortezomib: Phase II MCL-001 "EMERGE" Study


Goy A., Williams M. E. , Besisik S. , Drach J., Ramchandren R., Zhang L., ...More

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, vol.14, 2014 (Journal Indexed in SCI) identifier

  • Publication Type: Article / Abstract
  • Volume: 14
  • Publication Date: 2014
  • Doi Number: 10.1016/j.clml.2014.06.077
  • Title of Journal : CLINICAL LYMPHOMA MYELOMA & LEUKEMIA